Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Clovis Oncology Inc
(NQ:
CLVS
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Dec 20, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Clovis Oncology Inc
< Previous
1
2
3
4
5
6
7
Next >
12 Health Care Stocks Moving In Monday's Intraday Session
August 08, 2022
Via
Benzinga
Why Is Clovis Oncology (CLVS) Stock Down 10% Today?
August 08, 2022
Clovis Oncology is in the red today after a lackluster earnings report. CLVS stock is down 10% on missed profit and revenue.
Via
InvestorPlace
Clovis Oncology Needs Funding To Continue As Going Concern Beyond Early Next Year
August 08, 2022
Clovis Oncology Inc (NASDAQ: CLVS) said
Via
Benzinga
Recap: Clovis Oncology Q2 Earnings
August 08, 2022
Clovis Oncology (NASDAQ:CLVS) reported its Q2 earnings results on Monday, August 8, 2022 at 06:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Clovis Oncology Announces Second Quarter 2022 Operating Results and Provides Update on Clinical Development Programs
August 08, 2022
From
Clovis Oncology, Inc.
Via
Business Wire
Why Is Clovis Oncology (CLVS) Stock in the Spotlight Today?
July 07, 2022
Clovis (CLVS) stock is on investors' radars as its shareholder meeting is resuming today. The company is seeking approval for a reverse split.
Via
InvestorPlace
7 Penny Stocks to Buy Before the Bull Market Returns
August 01, 2022
With stocks in the doldrums, the time to take a look at these 7 penny stocks to buy before the bull market returns.
Via
InvestorPlace
CORRECTING and REPLACING Clovis Oncology to Announce Second Quarter 2022 Financial Results and Host Webcast Conference Call on August 8
July 20, 2022
From
Clovis Oncology, Inc.
Via
Business Wire
Clovis Oncology (CLVS) Stock Pops 7% on Supply Agreement
July 19, 2022
CLVS stock is rallying 7% after Clovis Oncology made a major deal with NorthStar Medical. Takeover speculation has swirled around Clovis.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
July 19, 2022
We're starting off the day with a breakdown of the biggest pre-market stock movers investors will want to watch on Tuesday!
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
July 15, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Most Active Equity Options For Midday - Monday, July 11
July 11, 2022
Here are the most active equity options for midday.
Via
Talk Markets
Is Clovis Oncology (CLVS) Stock the Next Big Squeeze?
July 08, 2022
Clovis Oncology is skyrocketing after being flagged as a top gamma squeeze candidate. Here's why investors should be watching CLVS stock.
Via
InvestorPlace
Dow Rises 75 Points; Kura Sushi USA Shares Spike Higher
July 08, 2022
U.S. stocks traded slightly higher toward the end of trading as investors digested the recent jobs report for the month of June.
Via
Benzinga
Tesla, Twitter And 76 Biggest Movers From Friday
July 11, 2022
Gainers Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
July 08, 2022
Via
Benzinga
Most Active Equity Options For Midday - Friday, July 8
July 08, 2022
Here are the most active equity options for midday.
Via
Talk Markets
Dow Turns Positive After Better-Than-Expected Jobs Report
July 08, 2022
U.S. stocks turned higher midway through as investors digested the recent jobs report for the month of June.
Via
Benzinga
Tesla, WD-40 Company And 40 Stocks Moving In Friday's Mid-Day Session
July 08, 2022
Gainers Aditxt, Inc. (NASDAQ: ADTX) shares surged 75.7% to $0.2812 after the company's Adimune therapeutic program completed a toxicology study indicating a favorable safety profile of ADI-100.
Via
Benzinga
Why U.S. Stocks Are Trading Lower Despite Upbeat Nonfarm Payrolls Report
July 08, 2022
U.S. stocks traded lower this morning following the release of jobs report for the month of June.
Via
Benzinga
Clovis Oncology (CLVS) Stock Gains as Shareholders Reject Reverse Stock Split
July 08, 2022
Clovis' (CLVS) shareholders decided to reject a proposal for a reverse split of CLVS stock. Clovis' shares appear to be rising on the news.
Via
InvestorPlace
Twitter And 20 Stocks Moving Premarket
July 08, 2022
Gainers Seritage Growth Properties (NYSE: SRG) rose 35.7% to $8.25 in pre-market trading after gaining around 10% on Thursday. Seritage Growth Properties filed its preliminary proxy materials with the...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
July 07, 2022
Gainers
Via
Benzinga
Why Are Meme Stocks AMC and GME Roaring Higher Today?
July 07, 2022
Meme stocks are a hot topic among traders on Thursday as investors react to recent news from AMC Entertainment (AMC) and GameStop (GME).
Via
InvestorPlace
Why U.S. Stocks Are Trading Higher After Rise In Jobless Claims
July 07, 2022
U.S. stocks traded higher this morning, following the release of data on initial jobless claims.
Via
Benzinga
The Daily Biotech Pulse: Merck's Seagen Buyout Advances, Adverum Restructures, Pharmacists Get OK To Prescribe Pfizer COVID-19 Pill
July 07, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
FDA's Recommendation Before Clovis Submits Rubraca Application For Ovarian Cancer
July 07, 2022
Earlier this month, Clovis Oncology Inc (NASDAQ: CLVS) had a Type A meeting with the FDA to discuss its plans for a supplemental marketing application for Rubraca (Rucaparib) as a first-line...
Via
Benzinga
Is Evofem Biosciences (EVFM) Stock the Next Big Squeeze?
July 06, 2022
Fintel has ranked Evofem Biosciences as the next top gamma squeeze. Will Meade noticed. Here's what this means for EVFM stock.
Via
InvestorPlace
Alphabet, Dyne Therapeutics And 74 Biggest Movers From Yesterday
July 06, 2022
Gainers Enjoy Technology, Inc. (NASDAQ: ENJY) shares jumped 81.5% to close at $0.31 on Tuesday.
Via
Benzinga
Most Active Equity Options For Midday - Tuesday, July 5
July 05, 2022
Here are the most active equity options for midday.
Via
Talk Markets
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.